Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study - 14/10/22

David Moreno-Ramírez, MD, PhD ^{a, ⁎} , Miguel A. Duarte-Ferreras, MD ^a, Teresa Ojeda-Vila, MD, PhD ^a, Irene García-Morales, MD, PhD ^a, Maria D. Conejo-Mir, MD ^a, Almudena Fernández-Orland, MD ^a, Ana I. Sánchez-del-Campo, MD ^a, Noemí Eiris, MD ^a, Ana M. Carrizosa, MD, PhD ^a, Andrés Ruiz-de-Casas, MD ^a, Jose M. de-la-Torre, MD ^a, Juan M. Herrerías-Esteban, MD ^b, Lara Ferrándiz, MD, PhD ^a

^a Dermatology Digital Center, Department of Medical and Surgical Dermatology, Seville, Spain 

^b Communication and Technology Department, Hospital Universitario Virgen Macarena, Seville, Spain 

^∗Correspondence to: David Moreno-Ramírez, MD, PhD, Dermatology Digital Center, Department of Medical and Surgical Dermatology, Hospital Universitario Virgen Macarena, Avda. Dr. Fedriani 3, Seville 41071, SpainDermatology Digital CenterDepartment of Medical and Surgical DermatologyHospital Universitario Virgen MacarenaAvda. Dr. Fedriani 3Seville41071Spain